Sylvie Gueguen
13ème Rue, LID
Carros, 06511, France
Carros, 06511, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy of a Modified-Live Virus Combination Vaccine (CDV, CAV, CPV, CPiV), CanigenTM DHPPi, in Puppies Vaccinated at Six Weeks of Age.
Journal: Viruses
Published: November 14, 2025
Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus.
Journal: BMC veterinary research
Published: December 12, 2016
The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later.
Journal: Veterinary research
Published: March 12, 2014
Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review.
Journal: Veterinary research
Published: March 07, 2014
A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to two leishmania infantum transmission seasons.
Journal: PLoS neglected tropical diseases
Published: January 17, 2014
Primary vaccination with the LiESP/QA-21 vaccine (CaniLeish) produces a cell-mediated immune response which is still present 1 year later.
Journal: Veterinary immunology and immunopathology
Published: November 13, 2013
Protective Efficacy of the Calicivirus Valency of the Leucofeligen Vaccine against a Virulent Heterologous Challenge in Kittens.
Journal: Veterinary medicine international
Published: February 19, 2013
Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs.
Journal: PLoS neglected tropical diseases
Published: January 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026